Where do stem cells come from? Learn the basics of these “master cells” to better understand their therapeutic potential and how they could revolutionize medicine as we know it. [Read more…]
Remote IT Support Software for Healthcare: Meeting HIPAA and Data Protection Requirements
A clinical researcher reaches out at 11 PM because the lab workstation will not connect to the freezer monitoring system. A patient record is open on her second screen. Whoever takes that ticket needs to fix the issue without ever pulling unauthorized eyes onto protected health information. Healthcare carries the heaviest breach cost of any industry at $7.42 million per incident for the 14th year running, per IBM’s 2025 report. The tool a hospital or biotech firm picks for remote help shapes whether that midnight ticket stays a routine fix or becomes the next OCR investigation. [Read more…]
TheWell Bioscience and PeptiGrowth Enter into Marketing Collaboration Agreement to Advance Next-Generation Cell Culture Solutions
Monmouth Junction, NJ and Tokyo, Japan — January 7, 2026 — TheWell Bioscience Inc., a biotechnology company pioneering next-generation animal-free biofunctional hydrogels, and PeptiGrowth Inc., a leader in innovative synthetic peptide growth factors, today announced that the two companies have entered into a Marketing Collaboration Agreement to jointly promote cutting-edge solutions for stem cell culture, organoid development, and cell therapy manufacturing. [Read more…]
Stem Cell Infusion: What to Expect
In recent years, stem cell infusion has become a breakthrough technology. There have been multiple medical leaders citing regenerative medicine as the way of the future. Stem cells obviate our need to patch up the body or create stopgap measures for systems that don’t work. They instead promise to replace organs and tissues that no longer function, essentially rebuilding the body from the inside out. Naturally, science has not progressed to the point of spreading this technology across the globe. However, the growing availability and efficacy of stem cell infusion indicate this isn’t far off, either. [Read more…]
Cord Blood and Tissue Banking Market Dynamics in 2026
The first transplant using cord blood-derived hematopoietic stem cells was performed in October 1988. Since that year, remarkable achievements have been made in terms of research into umbilical cord blood-derived hematopoietic and progenitor cells. More than 40,000 UCB transplants (UCBTs) have been performed across different geographies of the world, in both children and adults, to treat diseases that include hematologic, metabolic, immunologic, neoplastic, and neurologic disorders. [Read more…]
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 62
- Next Page »